A nurse caring for an older adult client notes reduced kidney function. How should this impact medication dosage calculations?

Age-related renal impairment involves decreased glomerular filtration rate, reduced tubular secretion, and declining renal blood flow, leading to impaired drug clearance, prolonged half-life, and increased risk of drug accumulation and toxicity especially for renally excreted medications. Rationale: A. Increasing the medication dose in reduced kidney function increases risk of drug toxicity due to impaired clearance. Accumulation occurs because elimination pathways are compromised. This can lead to adverse effects such as nephrotoxicity and central nervous system depression. Therefore dose escalation is contraindicated. B. Reducing the medication dose compensates for decreased renal clearance and prevents drug accumulation. It minimizes toxicity risk while maintaining therapeutic effectiveness. Dose adjustment is standard practice using renal function indicators such as creatinine clearance. This is the safest and most appropriate modification. C. Maintaining the same dose ignores physiological decline in renal excretory function. This increases risk of supratherapeutic levels and adverse drug reactions. Older adults are particularly vulnerable due to reduced physiological reserve. Therefore unchanged dosing is unsafe in renal impairment. D. Changing the medication formulation may alter absorption or route but does not address impaired renal elimination. Pharmacokinetic adjustment is primarily achieved through dose reduction. Formulation change alone does not prevent accumulation. Thus it is not the primary intervention for renal dysfunction.